Biotium

Biotium

Biotium is a leading biotechnology company that develops fluorescent reagents for life science research. With a focus on qPCR kits and highly sensitive staining reagents, including the completely non-toxic GelRed® and GelGreen® dyes, Biotium supports researchers worldwide in cell and molecular biology with innovative products.

Set Descending Direction

46579 items

per page
  1. TCL1 (T-Cell Marker) (TCL1/2747R), CF740 conjugate, 0.1mg/mL
    TCL1 (T-Cell Marker) (TCL1/2747R), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742747-100
    Manufact. SkuBNC742747-100
    Packaging Unit100 uL
  2. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742746-500
    Manufact. SkuBNC742746-500
    Packaging Unit500 uL
  3. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742746-100
    Manufact. SkuBNC742746-100
    Packaging Unit100 uL
  4. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2745), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2745), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742745-500
    Manufact. SkuBNC742745-500
    Packaging Unit500 uL
  5. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2745), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2745), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742745-100
    Manufact. SkuBNC742745-100
    Packaging Unit100 uL
  6. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742744-500
    Manufact. SkuBNC742744-500
    Packaging Unit500 uL
  7. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2744), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742744-100
    Manufact. SkuBNC742744-100
    Packaging Unit100 uL
  8. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742743-500
    Manufact. SkuBNC742743-500
    Packaging Unit500 uL
  9. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2743), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742743-100
    Manufact. SkuBNC742743-100
    Packaging Unit100 uL
  10. PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2742), CF740 conjugate, 0.1mg/mL
    PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)(PDL1/2742), CF740 conjugate, 0.1mg/mL
    Price is loading...
    Sku BTMBNC742742-500
    Manufact. SkuBNC742742-500
    Packaging Unit500 uL
Set Descending Direction

46579 items

per page